Dow Jones
33.761,05 +424,35 (+1,27%) Nasdaq
13.047,19 +267,29 (+2,09%) Nikkei 225
28.546,98 +727,68 (+2,62%) EUR/USD
1,0260 +0,0002 (+0,02%) BTC-EUR
23.713,15 -278,88 (-1,16%) CMC Crypto 200
580,10 +8,82 (+1,54%)
iRhythm Technologies, Inc. (0A7L.L)
| Chiusura precedente | 143,72 |
| Aperto | 151,09 |
| Denaro | 0,00 x N/D |
| Lettera | 0,00 x N/D |
| Min-Max giorno | 151,09 - 151,09 |
| Intervallo di 52 settimane | 151,09 - 151,09 |
| Volume | |
| Media Volume | N/D |
| Capitalizzazione | N/D |
| Beta (5 anni mensile) | 1,50 |
| Rapporto PE (ttm) | N/D |
| EPS (ttm) | -4,22 |
| Prossima data utili | 02 nov 2022 - 07 nov 2022 |
| Rendimento e dividendo (forward) | N/D (N/D) |
| Data ex dividendo | N/D |
| Stima target 1A | N/D |
- GlobeNewswire
iRhythm Technologies Announces Second Quarter 2022 Financial Results
SAN FRANCISCO, Aug. 04, 2022 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ: IRTC), a leading digital healthcare solutions company focused on the advancement of cardiac care, today reported financial results for the three months ended June 30, 2022. Second Quarter 2022 Financial Highlights Revenue of $102.1 million, a 25.6% increase compared to second quarter 2021Gross margin of 68.8%, a 0.8 percentage point improvement compared to second quarter 2021Cash and short-term investments of $2
- GlobeNewswire
iRhythm Technologies to Present at the Canaccord Genuity 42nd Annual Growth Conference
SAN FRANCISCO, July 28, 2022 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ:IRTC), a leading digital healthcare solutions company focused on the advancement of cardiac care, today announced the company will be participating in the upcoming Canaccord Genuity 42nd Annual Growth Stock Conference. iRhythm’s management is scheduled to present on Thursday, August 11, 2022, at 12:00 p.m. Eastern Time. Interested parties may access a live and archived webcast of the presentation on the “Investor
- GlobeNewswire
iRhythm Technologies Announces the Addition of Two Executive Leaders to Advance Strategic Growth and Operational Excellence
SAN FRANCISCO, July 25, 2022 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ:IRTC), a leading digital healthcare solutions company focused on the advancement of cardiac care, today announced the appointment of two seasoned executives to its leadership team. Brice Bobzien will join the company as the Chief Financial Officer on August 8, 2022, to lead all financial operations of the company as well as to advance the culture of operational excellence and prepare the company for future growth
